Our knowledge exhibit that CK18 is consistently expressed in different epithelial cancers, especially adenocarcinomas. each loss of CK18 expression in cancers derived from CK18 optimistic precursor cells and neo-expression in malignancies derived from CK18 favourable precursors tend to be linked to unfavorable tumor phenotype and disease end result